differ
diseas
may
caus
pathogen
malfunct
organ
use
therapeut
agent
heal
old
record
histori
small
molecul
convent
therapeut
candid
easili
synthes
administ
howev
mani
small
molecul
specif
target
may
lead
side
moreov
number
diseas
caus
due
defici
specif
protein
enzym
thu
treat
use
biolog
base
therapi
abl
recogn
specif
target
within
crowd
biolog
condit
macromolecul
protein
peptid
optim
recogn
specif
therefor
overrid
shortcom
small
recent
pharmaceut
scientist
shown
interest
engin
amino
acidbas
therapeut
protein
peptid
theoret
experiment
techniqu
predict
structur
fold
amino
acid
sequenc
provid
insight
structur
function
encod
sequenc
predict
may
valuabl
interpret
genom
inform
mani
life
process
moreov
engin
novel
protein
redesign
exist
protein
open
way
achiev
novel
biolog
macromolecul
desir
therapeut
protein
sequenc
compris
ten
thousand
amino
acid
besid
backbon
side
chain
degre
freedom
lead
larg
number
configur
singl
amino
acid
sequenc
protein
design
techniqu
give
minim
frustrat
precis
identif
sequenc
consid
energi
landscap
theori
adequ
minim
frustrat
natur
protein
occur
nativ
state
adequ
low
de
novo
design
sequenc
difficult
huge
number
possibl
sequenc
nresidu
protein
natur
amino
peptid
design
incorpor
comput
approach
benefit
search
advanc
field
use
small
molecul
protein
howev
straightforward
adopt
comput
approach
employ
smallmolecul
protein
design
accept
reason
solut
peptid
design
peptid
drug
design
conform
space
access
peptid
challeng
smallmolecul
comput
approach
besid
necess
nonstandard
amino
acid
variou
cycliz
chemistri
challeng
avail
tool
protein
furthermor
aggreg
peptid
drug
product
storag
unavoid
problem
peptid
design
procedur
ration
design
peptid
ligand
also
challeng
elus
affin
intrins
flexibl
peptidefocus
silico
method
increasingli
develop
make
testabl
predict
refin
design
hypothes
consequ
peptidefocus
approach
decreas
chemic
space
theoret
peptid
accept
focus
druglik
space
reduc
problem
associ
aggreg
discuss
follow
peptid
defin
rel
small
residu
polym
amino
physiolog
condit
sever
problem
degrad
specif
nonspecif
peptidas
may
limit
clinic
applic
natur
moreov
promiscu
peptid
receptor
emerg
high
degre
conform
flexibl
caus
undesir
side
besid
properti
therapeut
peptid
high
molecular
mass
low
chemic
stabil
result
weak
pharmacokinet
profil
therefor
peptidomimet
design
valuabl
solut
circumv
undesir
properti
therapeut
biolog
environ
peptidomimet
mimic
biolog
activ
parent
peptid
advantag
improv
pharmacokinet
pharmacodynam
properti
includ
bioavail
select
efficaci
stabil
wide
rang
peptidomimet
introduc
isol
natur
synthes
novel
design
base
xray
crystallograph
predict
mimic
biolog
manner
natur
use
hierarch
strategi
possibl
chang
peptid
mimic
deriv
lower
undesir
properti
origin
past
year
comput
method
develop
discov
part
review
novel
comput
method
introduc
peptidomimet
design
summar
peptidomimet
categor
follow
peptid
backbon
mimet
type
function
mimet
type
topograph
mimet
type
first
gener
peptidomimet
type
mimic
local
topographi
amid
bond
includ
amid
bond
short
fragment
secondari
structur
mimet
gener
match
peptid
backbon
atomforatom
compris
chemic
group
also
mimic
function
natur
side
chain
amino
acid
number
prosper
instanc
type
peptidomimet
second
type
peptidomimet
describ
function
mimet
type
mimet
includ
small
nonpeptid
compound
abl
identifi
biolog
target
parent
first
assum
conserv
structur
analog
parent
peptid
howev
use
sitedirect
mutagenesi
bind
site
biolog
target
investig
result
indic
type
peptidomimet
routin
bind
protein
site
differ
select
origin
therefor
type
mimet
maintain
abil
interfer
interact
process
without
necess
mimic
structur
natur
type
peptidomimet
reveal
best
concept
peptidomimet
consist
necessari
chemic
group
act
topograph
mimet
contain
novel
chemic
scaffold
unrel
natur
theoret
comput
techniqu
design
protein
peptid
peptidomimet
review
howev
current
review
deepli
highlight
comput
aspect
amino
acidbas
therapeut
design
discuss
method
use
design
mention
therapeut
figur
summar
key
concept
present
studi
exampl
structur
aldesleukin
leuprolid
spaglum
acid
import
amino
acidbas
therapeut
approv
us
food
drug
administr
fda
shown
figur
xray
crystallograph
structur
aldesleukin
pdb
id
figur
leuprolid
pdb
id
figur
obtain
protein
data
bank
pdb
http
wwwrcsborg
visual
pymol
tool
structur
spaglum
acid
retriev
mol
format
pubchem
databas
http
pubchemncbinlmnihgov
pubchem
id
figur
visual
use
pymol
aldesleukin
lymphokin
recombin
protein
use
treat
adult
metastat
renal
cell
carcinoma
http
leuprolid
synthet
nineresidu
peptid
analog
gonadotropin
releas
hormon
use
treat
advanc
prostat
cancer
http
spaglum
acid
use
allerg
condit
allerg
conjunct
drug
belong
class
peptidomimet
known
hybrid
peptid
hybrid
peptid
contain
least
two
dissimilar
type
amino
acid
alpha
beta
gamma
delta
link
via
peptid
bond
http
current
studi
fdaapprov
therapeut
retriev
drugbank
http
wwwdrugbank
cabiotechdrug
analysi
conduct
compar
percentag
proteinbas
therapi
gene
nucleic
acidbas
therapi
vaccin
allergen
cell
transplant
therapi
made
total
approv
therapeut
respect
smallmolecul
drug
made
approv
therapeut
figur
templat
also
name
scaffold
protein
contain
group
backbon
atom
coordin
coordin
retriev
avail
xray
crystal
structur
cautious
nuclear
magnet
reson
nmr
fix
backbon
decreas
comput
complic
may
inhibit
main
chain
modif
adjust
sequenc
backbon
flexibl
gener
design
function
protein
normal
function
backbon
flexibl
introduc
incorpor
close
associ
conform
exist
recent
new
function
effect
introduc
timbarrel
fold
detect
one
share
structur
distinct
protein
design
procedur
protein
sequenc
select
meet
energet
geometr
constraint
establish
chosen
fold
sequenc
search
techniqu
sampl
differ
sequenc
estim
energi
gain
one
owe
minimum
order
identifi
sequenc
subject
object
function
specif
energi
divers
strategi
includ
optim
probabilist
approach
optim
process
may
recogn
candid
sequenc
use
stochast
determinist
probabilist
approach
focu
character
sequenc
space
probabilist
determinist
method
achiev
sequenc
fold
global
minimum
energi
conform
determinist
method
search
whole
sequenc
space
identifi
global
method
includ
deadend
elimin
dee
selfconsist
mean
graph
decomposit
linear
stochast
algorithm
search
sequenc
space
exploratori
algorithm
includ
mont
carlo
algorithm
simul
anneal
graph
search
genet
commonli
use
method
discuss
dee
consid
thorough
search
algorithm
find
remov
sequencerotamer
posit
portion
global
minimum
energi
conform
dee
compar
two
amino
acid
rotam
remov
one
greater
interact
interact
energi
comput
rotam
test
amino
acid
along
rotam
everi
amino
situat
repetit
examin
total
amino
acid
state
well
rotam
longer
hold
expand
sequenc
length
increas
combinatori
complic
dee
exponenti
therefor
design
sequenc
amino
acid
larger
applic
dee
may
detail
theorem
explain
stochast
search
algorithm
mention
determinist
approach
perfect
design
protein
small
size
show
appli
disadvantag
extens
sequenc
size
stochast
heurist
method
valuabl
design
larg
wide
use
method
protein
design
includ
mont
carlo
mont
carlo
method
sampl
posit
complic
protein
way
relat
select
probabl
distribut
boltzmann
distribut
boltzmann
distribut
special
weigh
lowenergi
configur
mont
carlo
algorithm
perform
iter
seri
calcul
primari
step
search
partial
accident
test
sequenc
gener
energi
calcul
via
physic
potenti
primari
step
rotam
state
amino
acid
ident
adjust
effici
temperatur
control
probabl
energi
alter
next
step
name
simul
anneal
temperatur
gradual
decreas
permit
favor
sampl
lowerenergi
multipl
independ
calcul
carri
converg
system
global
explan
theorem
detail
formul
probabl
distribut
weight
reader
refer
studi
previou
probabilist
approach
probabilist
approach
frequent
employ
thorough
inform
access
protein
design
probabilist
approach
sitespecif
amino
acid
probabl
may
util
rather
particular
sequenc
procedur
partial
motiv
uncertainti
find
sequenc
consist
specif
structur
briefli
backbon
atom
fix
greatli
constrain
side
chain
conform
discret
handl
energi
function
estim
solvat
handl
simpl
howev
order
offer
valuabl
sequenc
inform
design
experi
find
structur
signific
amino
acid
probabilist
techniqu
leverag
structur
characterist
interatom
gener
mont
carlo
method
give
probabilist
sampl
addit
entropybas
formal
defin
predict
amino
acid
probabl
certain
backbon
method
employ
concept
statist
thermodynam
assess
sitespecif
probabl
address
whole
space
exist
composit
theori
restrict
comput
enumer
sampl
larg
protein
structur
variabl
residu
suppli
chemic
variabl
sequenc
number
variou
amino
acid
permit
posit
defin
degre
freedom
amino
acid
moreov
natur
residu
search
whole
sequenc
decreas
degre
freedom
amino
acid
search
sequenc
space
divers
approach
hydrophob
pattern
monom
use
probe
protein
improv
natur
occur
amino
side
chain
conform
typic
consist
energi
minima
molecular
potenti
obtain
structur
rotam
status
relat
repeatedli
detect
valu
dihedr
angl
side
chain
amino
acid
exampl
simplest
amino
acid
includ
alanin
glycin
one
rotam
statu
bigger
amino
acid
divers
rotam
varieti
rotam
librari
includ
backbon
depend
secondari
structuredepend
backboneindepend
librari
develop
protein
use
rotam
librari
one
discret
meaning
state
space
decreas
comput
difficulti
rotam
librari
extend
beyond
natur
amino
acid
effect
rotam
model
cofactor
ligand
water
posttransl
modif
exampl
improv
model
interact
model
water
within
protein
interior
structur
definit
water
molecul
insert
solvat
rotam
energi
function
employ
quantifi
includ
linear
associ
hydrogen
bond
made
backbon
atom
repuls
among
atom
hydrophob
attract
among
nonpolar
group
electrostat
interact
among
sequenti
sequenc
protein
select
adjust
energet
geometr
constraint
enforc
favorit
fold
constraint
typic
contain
sever
intramolecular
interact
van
der
waal
hydrophob
polar
electrostat
interact
well
hydrogen
bond
gener
use
score
function
possibl
energet
contribut
mention
paramet
taken
assembl
protein
secondarystructur
novel
structur
model
de
novo
design
procedur
backbon
coordin
gener
constrain
summari
import
find
protein
design
use
comput
approach
includ
retroaldol
kemp
elimin
novel
redesign
novel
protein
structur
shown
tabl
ligandbas
design
classifi
follow
sequencebas
propertybas
conformationbas
design
sequencebas
approach
use
inform
conserv
region
analyz
multipl
sequenc
align
method
direct
hypothesi
conserv
region
function
structur
comput
tool
allow
ligandbas
peptid
design
although
lag
behind
bioinformat
strategi
develop
protein
recent
use
method
base
matrix
relationship
seri
collagen
peptid
antiangiogen
activ
includ
prolifer
migrat
adhes
matrix
captur
inform
mutat
rate
among
pair
amino
acid
base
result
region
c
n
termini
peptid
detect
signific
ideal
activ
suggest
two
distinct
bind
site
approach
show
potenti
worth
sequencebas
peptid
anoth
report
comput
platform
call
sarvis
develop
support
sequencebas
design
sarvis
signifi
import
step
peptid
sequenceact
relationship
sar
analysi
moreov
pool
improv
visual
abil
advanc
sequenceact
compar
small
molecul
propertybas
design
method
peptid
earli
stage
develop
recent
studi
decomposit
per
residu
physicochem
characterist
amino
acid
hydrophil
hydrophob
volum
use
model
peptid
bind
target
final
model
built
estim
peptid
valu
bind
class
major
histocompat
complex
mhc
protein
hlaa
furthermor
wide
rang
studi
antimicrobi
peptid
success
analyz
use
propertybas
exampl
machinelearn
method
employ
design
novel
antimicrobi
victori
propertybas
method
antimicrobi
peptid
may
explain
fact
desir
biolog
activ
membran
disrupt
rel
case
conformationbas
peptid
design
comput
techniqu
develop
predict
conform
ensembl
structur
peptid
analyz
pepfold
onlin
tool
use
predict
structur
peptid
length
remark
suggest
data
pepfold
seem
solv
conform
sampl
order
search
conform
space
peptid
long
timescal
molecular
dynam
simul
besid
quantum
mechan
calcul
promis
address
score
defici
peptid
conform
appar
affect
peptid
design
process
posit
improv
major
theoret
technic
issu
necessari
comput
sophist
costli
procedur
conform
peptid
may
model
gener
pharmacophor
hypothesi
certain
pharmacophor
hypothesi
use
determin
admetox
activ
particular
potenc
exampl
screen
peptid
librari
joint
gener
pharmacophor
hypothesi
identifi
potent
agonist
receptor
isoform
combinatori
tetrapeptid
librari
screen
sar
ligandderiv
pharmacophor
templat
gener
pharmacophor
hypothesi
propos
allow
continu
attempt
ration
design
melanocortin
receptor
recent
increas
number
structur
deposit
pdb
assist
search
molecular
mechan
structur
basi
peptid
recognit
inform
crystal
structur
complex
improv
knowledg
chemic
forc
involv
bind
special
mode
bind
dynam
data
complex
partial
extract
solut
nmr
structur
deposit
pdb
record
structur
function
variou
complex
experiment
resolv
structur
data
gather
annot
analyz
sever
distinct
databas
peptiddb
pepx
databas
deriv
pdb
compris
uniqu
interfac
pepbind
databas
contain
complex
structur
peptiddb
curat
databas
abund
structur
inform
specif
monomer
protein
could
gather
design
interact
requir
sequenc
precis
dock
highli
flexibl
peptid
major
tradit
dock
protocol
autodock
develop
dock
small
molecul
also
use
dock
peptid
protein
receptor
howev
compar
studi
reveal
techniqu
would
face
failur
dock
peptid
residu
therefor
develop
peptidefocus
dock
protocol
dock
tool
zdock
hex
use
comput
peptid
design
detail
recent
develop
peptidefocus
dock
approach
discuss
first
heurist
evolut
procedur
appli
search
larg
conform
space
linear
peptid
howev
procedur
effici
use
scheme
base
conform
sampl
becam
common
peptid
dock
besid
sever
illustr
approach
propos
balanc
accuraci
efficaci
flexibl
peptid
dock
aspect
integr
onlin
userfriendli
interfac
introduc
recent
develop
peptid
dock
report
subangstrom
accuraci
reproduc
crystal
structur
flexpepdockbas
method
assum
previou
inform
peptidebind
anchordock
recent
describ
algorithm
allow
power
blind
dock
calcul
relax
program
predict
anchor
origin
protein
surfac
follow
recognit
anchor
origin
assum
peptid
conform
refin
use
anchorconstrain
molecular
dynam
haddock
wellknown
dock
tool
recent
expand
run
flexibl
handl
dock
procedur
haddock
use
ambigu
interact
restraint
base
experiment
inform
intermolecular
interact
rigid
bodi
peptid
dock
follow
flexiblesimul
anneal
process
novel
haddock
strategi
initi
dock
comput
ensembl
three
dissimilar
peptid
conform
eg
extend
polyprolineii
high
inform
cabsdock
recent
introduc
dock
tool
run
primari
dock
procedur
whose
outcom
refin
tool
primari
phase
procedur
random
conform
peptid
predict
locat
around
protein
target
interest
process
follow
replica
exchang
mont
carlo
dynam
subsequ
model
select
last
optim
use
model
tool
gain
accur
score
rank
galaxypepdock
develop
use
experiment
resolv
structur
run
templatebas
dock
pool
flexibl
energybas
atomist
mont
carlo
molecular
dynam
simul
accur
meticul
techniqu
investig
bind
interact
techniqu
also
detect
thermodynam
profil
trajectori
includ
identif
method
predict
associ
among
conform
peptid
solut
studi
order
describ
bind
decapeptid
cognat
receptor
longterm
molecular
dynam
simul
use
twostat
model
first
step
rel
quick
diffus
phase
nonspecif
encount
complex
gener
stabil
use
electrostat
energi
secondari
step
slow
modif
phase
water
molecul
empti
space
peptid
ligand
anoth
report
use
mont
carlo
method
mention
twostat
model
verifi
trace
oligopeptid
rout
bind
variou
pdz
post
synapt
densiti
protein
drosophila
disc
larg
tumor
suppressor
zonula
protein
affin
peptid
protein
investig
result
show
higher
affin
bound
peptid
occur
correspond
peptid
lower
degre
disord
unbound
state
vice
result
show
highli
structur
peptid
could
increas
affin
reduc
entrop
loss
associ
bind
overal
addit
electrostat
hydrophob
forc
interact
affect
entrop
effect
conform
flexibl
could
willingli
examin
atomist
recent
use
fast
molecular
dynam
simul
energet
dynam
featur
interact
studi
case
nativ
bind
site
nativelik
postur
complex
recapitul
addit
investig
show
insert
motil
flexibl
simul
could
meaning
advanc
correct
bind
featur
comput
peptid
design
base
accuraci
efficaci
affin
predict
henc
fast
reliabl
predict
affin
signific
ration
peptid
aspect
two
categori
predict
algorithm
includ
sequenc
structurebas
approach
develop
sequencebas
method
use
inform
deriv
primari
polypeptid
sequenc
approxim
evalu
standard
bind
affin
structurebas
process
take
inform
deriv
structur
complex
predict
bind
sequenc
level
quantit
relationship
qsar
wide
util
forecast
bind
affin
peptid
conclud
biolog
model
statist
correl
sequenc
pattern
biolog
activ
experiment
assess
peptid
machinelearn
method
partial
least
squar
pl
artifici
neural
network
ann
support
vector
machin
svm
use
obtain
correl
use
infer
experiment
undetermin
relationship
biolog
activ
molecular
structur
import
issu
biolog
biochemistri
qsar
wellestablish
method
employ
pharmaceut
chemistri
becom
standard
tool
drug
discoveri
howev
predict
capac
qsar
techniqu
gener
weaker
statisticsbas
approach
therefor
combin
qsar
method
statisticbas
techniqu
may
bring
best
trend
futur
develop
drug
structur
level
numer
report
affin
predict
address
mhcbind
peptid
plenti
complex
structur
record
deposit
signific
domainpeptid
recognit
recent
illustr
metabol
pathway
cell
predict
bind
potenc
number
strict
theori
suggest
base
potenti
free
energi
perturb
theori
comput
alter
free
energi
upon
interact
phosphortyrosinetetrapeptid
pyeei
human
lck
furthermor
obtain
deep
insight
structur
energet
aspect
peptid
recognit
domain
number
molecular
model
experi
homolog
model
molecular
dock
mechan
dynam
peptid
array
strategi
confirm
peptid
candid
may
potent
binder
abl
recent
approach
includ
quantum
mechanicsmolecular
mechan
semiempir
area
empir
conform
free
energi
analysi
develop
quantit
illustr
energet
contribut
involv
affin
lose
pdz
domain
oppa
protein
peptid
recent
order
de
novo
targetbas
peptid
design
two
remark
methodolog
includ
vital
method
approach
develop
bhattacherje
wallin
introduc
vital
method
pool
verterbi
algorithm
autodock
design
peptid
bind
site
bhattacherje
wallin
approach
explor
peptid
sequenc
conform
space
around
protein
target
approach
test
three
dissimilar
domain
assess
brief
list
exist
comput
resourc
employ
peptid
design
present
tabl
recent
year
comput
method
propos
design
peptidomimet
method
classifi
base
specif
translat
peptid
select
best
method
awar
structur
complex
herein
recent
introduc
method
computeraid
design
peptidomimet
present
growmol
combinatori
algorithm
employ
peptidomimet
design
growmol
search
varieti
probabl
ligand
bind
site
target
produc
molecul
chemic
steric
complementar
structur
bind
site
method
use
gener
peptidomimet
inhibitor
thermolysin
hiv
proteas
pepsin
use
xray
crystal
structur
complex
growmol
predict
therapeut
peptidomimet
aspart
proteas
algorithm
creat
cyclic
inhibitor
bridg
side
chain
cystein
residu
pl
inhibitor
subsit
bind
mode
check
use
xray
ludi
anoth
interest
softwar
refer
de
novo
use
natur
nonnatur
amino
acid
build
block
softwar
design
peptidomimet
renin
thermolysin
conform
flexibl
novel
peptidomimet
search
sampl
multipl
conform
amino
peptidedriven
pharmacophor
hypothesi
percept
comput
techniqu
discov
peptidomimet
design
method
especi
use
xray
structur
complex
main
idea
adapt
hot
spot
concept
associ
pharmacophor
featur
concept
pharmacophorebas
virtual
screen
process
strategi
determin
novel
type
fact
side
chain
amino
acid
simpli
categor
base
convent
pharmacophor
characterist
hydrogen
bond
donor
acceptor
aromat
ring
charg
hydrophob
center
exampl
report
pharmacophor
model
direct
synthesi
nonpeptid
analog
cation
antimicrobi
peptid
identifi
antistaphylococc
make
pharmacophor
hypothesi
model
rna
iiiinhibit
peptid
rip
wellknown
heptapeptid
inhibitor
staphylococc
pathogenesi
util
virtual
screen
commerci
avail
small
molecul
base
ripbas
pharmacophor
hamamelitannin
discov
nonpeptid
mimet
rip
hamamelitannin
tannin
deriv
extract
hamam
anoth
studi
two
round
silico
screen
perform
discov
potenti
peptidomimet
abl
mimic
cyclic
peptid
cyclo
cpfvktqlc
known
bind
integrin
end
process
potent
repres
least
time
better
origin
cyclopeptid
around
mm
prosper
instanc
virtual
screen
done
use
multiconform
form
larg
commerci
librari
targetbas
pharmacophor
model
map
site
pharmacophor
hypothesi
made
base
homolog
model
protein
caviti
cellbas
assay
two
top
score
molecul
detect
micromolar
inhibitor
pharmacophorebas
screen
use
find
novel
alzheim
therapeut
mimet
therapeut
util
neurotrophin
might
restrict
sever
defici
reduc
central
nervou
system
penetr
decreas
stabil
potenc
enhanc
neuron
death
interact
receptor
mimet
particular
nerv
growth
factor
domain
could
inhibit
neuron
death
peptidomimet
loop
loop
domain
nerv
growth
factor
prevent
neuron
death
induc
trkrelat
anoth
studi
fullcomput
pharmacophorebas
approach
assess
fdaapprov
drug
valuabl
candid
inhibit
peptid
structur
design
term
pharmacophor
search
fdaapprov
drug
detect
molecul
top
rank
drug
match
contain
sever
nuclear
receptor
ligand
match
alloster
bind
site
target
protein
top
rank
drug
match
dock
peptidebind
site
major
toprank
match
present
neg
free
energi
chang
upon
bind
compar
standard
geometri
similar
method
creat
geometr
similar
nonpeptid
templat
peptid
patch
studi
supermim
tool
develop
recogn
peptid
program
complex
librari
peptidomimet
compos
sever
protein
structur
librari
deposit
moreov
supermim
includ
dpeptid
synthet
compon
report
betaturn
gammaturn
mimet
peptidomimet
ligand
obtain
program
search
process
allow
scan
librari
small
molecul
mimic
tertiari
structur
queri
peptid
follow
scan
protein
librari
queri
small
molecul
adopt
recent
method
develop
rank
peptid
compound
match
limit
short
linear
motif
protein
compound
amino
acid
algorithm
allow
map
side
chainlik
substitu
everi
compound
larg
chemic
librari
complet
molecul
signifi
short
sequenc
fragment
molecul
repres
distinct
letter
crosssearch
pubchem
databas
million
molecul
nonredund
collect
peptid
obtain
pdb
demonstr
algorithm
use
highthroughput
recogn
true
posit
method
explor
identifi
protein
motif
nation
cancer
institut
development
therapeut
program
compound
anoth
studi
similar
amino
acid
motif
compound
web
server
develop
eas
screen
identifi
motif
structur
bioactiv
compound
methodolog
report
effici
sinc
compound
databas
preprocess
maxim
access
data
necessari
input
data
similar
amino
acid
motif
compound
motif
match
full
partial
may
decreas
enhanc
number
potenti
mimet
respect
use
novel
search
algorithm
web
servic
perform
fast
screen
known
put
motif
readi
compound
librari
classifi
result
examin
link
appropri
replac
partial
ligand
altern
comput
enrich
fragmentbas
use
structur
peptidebound
protein
design
anchor
program
comput
find
nonpeptid
mimet
specif
determin
known
peptid
develop
applic
strategi
pharmacophor
model
indic
medicin
chemistri
commun
broadli
accept
intuit
natur
pharmacophor
concept
besid
shape
complementar
identifi
signific
element
molecular
identif
ligand
virtual
screen
effort
use
pharmacophor
shapebas
techniqu
distinctli
may
increas
rate
falseposit
therefor
incorpor
pharmacophor
shapematch
techniqu
one
program
potenti
diminish
rate
fals
recent
discov
novel
peptidomimet
webori
virtual
screen
tool
name
develop
pool
convent
pharmacophor
match
shape
complementar
librari
million
conform
extract
million
commerci
avail
chemic
gather
mmsinc
databas
databas
use
skeleton
develop
pepmmsmim
interfac
structur
proteinbound
peptid
use
input
chemic
structur
abl
mimic
pharmacophor
shape
similar
origin
peptid
propos
involv
list
silico
method
use
design
potenti
peptidomimet
along
strength
weak
present
tabl
overal
design
develop
therapeut
tediou
expens
timeconsum
procedur
therefor
use
modern
approach
includ
computeraid
design
method
lessen
examin
phase
price
failur
therapeut
discoveri
comput
method
use
design
amino
acidbas
therapeut
increas
rang
avail
biotherapeut
benefit
dramat
advanc
bioinformat
comput
tool
use
find
develop
therapeut
protein
peptid
moreov
use
comput
tool
decreas
cost
therapeut
develop
concept
market
howev
comput
protein
design
challeng
inadequ
knowledg
fold
physic
forc
stabil
protein
structur
moreov
sequenc
local
structur
mani
degre
freedom
complic
sequenc
search
therefor
requir
effect
method
find
sequenc
relat
particular
structur
measur
essenti
protein
fold
criteria
overal
silico
design
amino
acidbas
therapeut
includ
mani
challeng
remov
improv
overal
perform
design
process
exampl
although
structur
determin
diseaserel
protein
crystallographi
nmr
labori
task
necessari
gather
much
structur
inform
interact
besid
develop
vigor
algorithm
calcul
bind
energi
essenti
estim
bind
constant
two
macromolecul
appropri
tradeoff
need
millisecond
scale
molecular
dynam
moreov
understand
recognit
process
molecular
level
improv
use
higher
accur
forc
field
quantum
mechan
polariz
forc
recent
year
grow
exampl
approv
monoclon
antibodi
therapeut
antibodi
fda
treatment
variou
diseas
import
area
amino
acidbas
therapeut
cover
depth
explan
theorem
detail
antibodi
informat
drug
discoveri
well
computeraid
antibodi
design
reader
refer
studi
previou
